The new pathways created by digital advances in the Life Sciences sector offer R&D actors the opportunity to improve processes, efficiency, and results, all to strengthen the development of their innovations. These advances are now influencing the structure of entire organisations, creating new roles, requiring new skills, and calling for collaboration with new players. How is the digitalisation of the sector driving the appetite of industrials and entailing new collaborations? How is the change of interlocutors in organisations characterised in the context of collaborations between academic researchers, clinicians, and industry?
Moderator: Didier Tranchier, Co-Founder and Program Director, Digital Pharma Lab 
